Study aims to perfect epidural dose for faster labor pain relief
NCT ID NCT07076368
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests different amounts of a common epidural medicine (ropivacaine and fentanyl) to find the dose that works best within 30 minutes for women in labor. About 50 pregnant women with a single baby in active labor will receive the epidural through a special technique. Researchers will measure pain scores and side effects to improve pain relief during childbirth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ropivacaine and fentanyl (epidural)
- What this could lead to
- If successful, this could help doctors use the smallest effective dose of epidural medicine for faster, safer labor pain relief.
- What could go wrong
- This is a small, early-phase study focused on dosing, not a new treatment. Results may not apply to all women, and side effects like low blood pressure or itching are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LABOR ANALGESIA are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, San Francisco
RECRUITINGSan Francisco, California, 94158, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a class tame pregnancy stress at the genetic level?
- A nationwide test: do home visits build healthier families?
- Can a simple calcium tablet help prevent postpartum bleeding?
- Can AI read ultrasound sweeps to tell Baby's position?
- Could a smart ring unlock secrets of pregnancy health?
- Could Video-Led pelvic exercises redefine prenatal care?